Live feed19:36:13·309dINSIDERFilingvia QuantisnowChief Commercial Officer Merendino Lauren converted options into 10,536 shares and sold $25,485 worth of shares (3,766 units at $6.77), increasing direct ownership by 19% to 41,931 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.DAWN· Day One Biopharmaceuticals Inc.Health CareOriginal source